Testing Magnetic Therapy for Frailty in Older Adults
Pilot-testing the Effect of Magnetic Mitohormesis Therapy for Treating Frailty in Older Adults
This study is testing if a new magnetic therapy can help older adults who are frail improve their physical strength and function.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 30 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Auburn University Academic / other |
| Locations | 1 site (Auburn, Alabama) |
| Trial ID | NCT05930470 on ClinicalTrials.gov |
What this trial studies
This pilot trial aims to evaluate the effectiveness of Magnetic Mitohormesis Therapy (MMT) in improving physical function among older adults experiencing frailty. Thirty participants will be randomly assigned to receive either MMT or a sham treatment over a 12-week period, with each participant undergoing both treatments in a crossover design. The study will assess changes in physical performance using standardized measures to determine the therapy's impact on frailty.
Who should consider this trial
Good fit: Ideal candidates are older adults with physical frailty or pre-frailty, as indicated by a Short Physical Performance Battery Score of less than 10.
Not a fit: Patients with active malignancies, neuro-degenerative diseases, or significant health conditions that prevent participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could enhance physical performance and overall quality of life for frail older adults.
How similar studies have performed: While this approach is novel, similar interventions targeting frailty have shown promise in other studies, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * physical frailty or pre-frailty, indicated by Short Physical Performance Battery Score \<10; * intact cognition indicated by a Mini-Cog Screening Test Score \> 2; * able to read and write in English; and * access to a telephone. Exclusion Criteria: * active malignancy; * neuro-degenerative disease * active electronic implants; * any health conditions that would prevent performing the testing and intervention procedures; * major surgical procedures within the last 6 months; * major change in prescription medications within the last 3 months
Where this trial is running
Auburn, Alabama
- Auburn University — Auburn, Alabama, United States (Recruiting)
Study contacts
- Principal investigator: Pao-Feng Tsai, PhD — Auburn University
- Study coordinator: Pao-Feng Tsai, PhD
- Email: tsaipaofeng@auburn.edu
- Phone: 334-844-5665
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.